Pathogenesis of Atherosclerosis

Journal of the American College of Cardiology

Volumn 47, Issue 8 SUPPL., 2006, Pages

  Falk, Erling ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN;

ARTERY CALCIFICATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW; CELL DEATH; CLINICAL FEATURE; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOOTH MUSCLE FIBER; THROMBOCYTE; ARTICLE; PATHOLOGY; PATHOPHYSIOLOGY;

ATHEROSCLEROSIS; HUMANS;

EID: 33646065983     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.09.068     Document Type: Review

References (44)

1. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part I. Circulation 108 (2003) 1664-1672
2. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part II. Circulation 108 (2003) 1772-1778
3. Spagnoli L.G., Mauriello A., Sangiorgi G., et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292 (2004) 1845-1852
4. Casscells W., Naghavi M., and Willerson J.T. Vulnerable atherosclerotic plaque. a multifocal disease. Circulation 107 (2003) 2072-2075
5. Glass C.K., and Witztum J.L. Atherosclerosis. The road ahead. Cell 104 (2001) 503-516
6. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
7. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. a randomized controlled trial. JAMA 290 (2003) 2292-2300
8. Wang X., Ishimori N., Korstanje R., Rollins J., and Paigen B. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 77 (2005) 1-15
9. Wald N.J., and Law M.R. A strategy to reduce cardiovascular disease by more than 80%. BMJ 326 (2003) 1419-1424
10. Law M.R., Wald N.J., and Morris J.K. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen 11 (2004) 3-7
11. Cunningham K.S., and Gotlieb A.I. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 85 (2005) 9-23
12. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
13. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
14. Davies M.J., Woolf N., Rowles P.M., and Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 60 (1988) 459-464
15. Willerson J.T., and Kereiakes D.J. Endothelial dysfunction. Circulation 108 (2003) 2060-2061
16. Houtkamp M.A., de Boer O.J., van der Loos C.M., van der Wal A.C., and Becker A.E. Adventitial infiltrates associated with advanced atherosclerotic plaques. structural organization suggests generation of local humoral immune responses. J Pathol 193 (2001) 263-269
17. Kaartinen M., van der Wal A.C., van der Loos C.M., et al. Mast cell infiltration in acute coronary syndromes. implications for plaque rupture. J Am Coll Cardiol 32 (1998) 606-612
18. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
19. Nilsson J., Hansson G.K., and Shah P.K. Immunomodulation of atherosclerosis. implications for vaccine development. Arterioscler Thromb Vasc Biol 25 (2005) 18-28
20. Kragel A.H., Reddy S.G., Wittes J.T., and Roberts W.C. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 80 (1989) 1747-1756
21. Schwartz S.M., Virmani R., and Rosenfeld M.E. The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2 (2000) 422-429
22. Geng Y.J., and Libby P. Progression of atheroma. a struggle between death and procreation. Arterioscler Thromb Vasc Biol 22 (2002) 1370-1380
23. Kolodgie F.D., Petrov A., Virmani R., et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V. a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108 (2003) 3134-3139
24. Guyton J.R. Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins. a mechanism for atherogenic lipid accumulation. Arterioscler Thromb Vasc Biol 21 (2001) 884-886
25. Tedgui A., and Mallat Z. Apoptosis as a determinant of atherothrombosis. Thromb Haemost 86 (2001) 420-426
26. Llodrá J., Angeli V., Liu J., Trogan E., Fisher E.A., and Randolph G.J. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 101 (2004) 11779-11784
27. Hoffmann U., Brady T.J., and Muller J. Cardiology patient page. Use of new imaging techniques to screen for coronary artery disease. Circulation 108 (2003) e50-e53
28. Pletcher M.J., Tice J.A., Pignone M., and Browner W.S. Using the coronary artery calcium score to predict coronary heart disease events. a systematic review and meta-analysis. Arch Intern Med 164 (2004) 1285-1292
29. Beckman J.A., Ganz J., Creager M.A., Ganz P., and Kinlay S. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 21 (2001) 1618-1622
30. Ehara S., Kobayashi Y., Yoshiyama M., et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction. an intravascular ultrasound study. Circulation 110 (2004) 3424-3429
31. Barger A.C., Beeuwkes III R., Lainey L.L., and Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310 (1984) 175-177
32. Kolodgie F.D., Gold H.K., Burke A.P., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003) 2316-2325
33. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25 (2005) 2054-2061
34. Casscells W., Hassan K., Vaseghi M.F., et al. Plaque blush, branch location, and calcification are angiographic predictors of progression of mild to moderate coronary stenoses. Am Heart J 145 (2003) 813-820
35. Davies M.J., and Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 310 (1984) 1137-1140
36. Vink A., Schoneveld A.H., Richard W., et al. Plaque burden, arterial remodeling and plaque vulnerability. determined by systemic factors?. J Am Coll Cardiol 38 (2001) 718-723
37. Schaar J.A., Muller J.E., Falk E., et al. Terminology for high-risk and vulnerable coronary artery plaques. Eur Heart J 25 (2004) 1077-1082
38. Falk E. Multiple culprits in acute coronary syndromes. systemic disease calling for systemic treatment. Ital Heart J 1 (2000) 835-838
39. Mann J., and Davies M.J. Mechanisms of progression in native coronary artery disease. role of healed plaque disruption. Heart 82 (1999) 265-268
40. Burke A.P., Kolodgie F.D., Farb A., et al. Healed plaque ruptures and sudden coronary death. evidence that subclinical rupture has a role in plaque progression. Circulation 103 (2001) 934-940
41. Falk E., Shah P.K., and Fuster V. Atherothrombosis and thrombosis-prone plaques. In: Fuster V., Alexander R.W., O'Rourke R.A., et al. (Eds). Hurst's the Heart. 11th edition (2004), McGraw-Hill, New York, NY 1123-1139
42. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 13 (2003) 249-253
43. Caplice N.M., Bunch T.J., Stalboerger P.G., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100 (2003) 4754-4759
44. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600